Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Parvin Zulfugarova has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synthesis and Antibacterial Evaluation of Silver-Coated Magnetic Iron Oxide/Activated Carbon Nanoparticles Derived from Hibiscus esculentus

    by Müslüm Güneş, Erdal Ertaş, Seyhmus Tumur, Parvin Zulfugarova, Fidan Nuriyeva, Taras Kavetskyy, Yuliia Kukhazh, Pavlo Grozdov, Ondrej Šauša, Oleh Smutok, et al.

    The increasing prevalence of antimicrobial resistance alongside the pharmacological limitations and adverse effects associated with conventional antibiotics necessitates the development of novel and efficacious antimicrobial agents. In this study, magnetic iron oxide nanoparticles (MIONPs) were synthesized via a chemical co-precipitation method. Activated carbon (AC) derived from Hibiscus esculentus (HE) fruit was coated onto the nanoparticle surfaces to fabricate MIONPs/HEAC nanocomposites. To augment their antimicrobial properties, silver ions were chemically reduced and deposited onto the MIONPs/HEAC surface, yielding MIONPs/HEAC@Ag nanocomposites. Comprehensive characterization of the synthesized nanocomposites was performed using scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), vibrating sample magnetometry (VSM), dynamic light scattering (DLS), and zeta potential analysis. DLS measurements indicated average particle sizes of approximately 122 nm and 164 nm for MIONPs/HEAC and MIONPs/HEAC@Ag, respectively. Saturation magnetization values were determined to be 73.6 emu/g for MIONPs and 65.5 emu/g for MIONPs/HEAC. Antibacterial assays demonstrated that MIONPs/HEAC@Ag exhibited significant inhibitory effects against Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923, with inhibition zone diameters of 11.50 mm and 13.00 mm, respectively. In contrast, uncoated MIONPs/HEAC showed negligible antibacterial activity against both bacterial strains. These findings indicate that MIONPs/HEAC@Ag nanocomposites possess considerable potential as antimicrobial agents for biomedical applications, particularly in addressing infections caused by antibiotic-resistant bacteria.


  • Open Access

    Synthesis and Antibacterial Evaluation of Silver-Coated Magnetic Iron Oxide/Activated Carbon Nanoparticles Derived from Hibiscus esculentus

    by Muslum Gunes, Erdal Ertaş, Seyhmus Tumur, Parvin Zulfugarova, Fidan Nuriyeva, Taras Kavetskyy, Yuliia Kukhazh, Pavlo Grozdov, Ondrej Šauša, Oleh Smutok, et al.

    The rise of antimicrobial resistance due to the indiscriminate use of antibiotics has become a global health crisis, contributing to millions of deaths each year. Given the limitations and side effects associated with current antibiotics, there is an urgent need to develop alternative antimicrobial agents that are both safe and effective. In this study, magnetic iron oxide nanoparticles (MIONPs) were synthesized via a chemical co-precipitation technique involving the simultaneous precipitation of Fe²⁺ and Fe³⁺ ions in an alkaline medium and supported on activated carbon (AC) derived from Hibiscus esculentus (HE) fruits, resulting in the formation of MIONPs/HEAC nanocomposites. To enhance their antimicrobial activity, these nanocomposites were further modified with a silver coating via the chemical reduction of silver ions using sodium borohydride, producing MIONPs/HEAC@Ag. The structure and properties of the nanoparticles were analyzed using various techniques. SEM and EDX were used to observe morphology and elemental makeup. DLS and zeta potential measured the size and surface charge. FTIR identified functional groups, and XRD determined crystallinity. The antibacterial activity of MIONPs/HEAC and MIONPs/HEAC@Ag was evaluated against bacterial strains of Escherichia coli and Staphylococcus aureus. The uncoated MIONPs/HEAC showed no antibacterial effect, whereas the MIONPs/HEAC@Ag exhibited significant antibacterial activity, with inhibition zones measuring 11.50 mm for E. coli and 13.00 mm for S. aureus. These results highlight the potential of MIONPs/HEAC@Ag nanocomposites as promising candidates for biomedical applications, particularly in addressing infections caused by antibiotic-resistant bacteria.